SOLUTION: ERT’s virtual trial capabilities can improve the oncology patient experience by reducing travel and site visit requirements. We power at-home data collection with convenient, patient-centric solutions that ensure quality, fidelity, and timeliness of delivery. To learn more about our virtual capabilities, click here.

It takes approximately 10.5 years for an oncology drug to make it to market. Sadly, this isn’t quick enough for many cancer patients.

SOLUTION:

ERT’s library of eCOA oncology assessments gets you to First-Patient-In 50% faster, while delivering more predictable timelines. Tox database. 

Our centralized cardiac safety and imaging technologies automate inefficient and error-prone manual processes, including secure data transfer and verification of source documents. Our ability to centralize your oncology trial data can eliminate transcription errors and reduce other delays by shortening recruitment timelines and helping you achieve database lock faster.

In clinical trials, having the ability to make go/no-go decisions faster is vital when time is of the essence. With ERT’s Trial Oversight solution, you can keep your studies on track by viewing your study performance data in near real-time.

SOLUTION: Motivated sites are more likely to achieve higher patient recruitment and retention levels. Sponsors and CROs can improve the site’s clinical trial experience by making participation as simple and convenient as possible.

ERT reduces site burden by simplifying participation and saving time. We provide 24/7 customer service support, flexible training as well as real-time monitoring of patient compliance and safety levels. Using a single login, sites can easily access their patient data and take advantage of automatic alerts when pre-set thresholds are reached on safety or compliance levels, enabling them to take action quickly.

SOLUTION: In oncology trials, every patient counts. ERT’s advanced technology ensures you’re not excluding eligible patients for both cardiac safety reads and overreads

We also ensure patients are at the heart of protocol design to drive patient engagement and retention. Our science team advises on the most appropriate data capture solution to help:

• Reduce site visits and time spent at site through, for example Virtual Video Visits, wearables or at-home blood pressure monitoring
• Making participation easier: our choice of devices fit in with patients’ lifestyles and expectations and our patient engagement strategies include the use of notifications as well as motivational and educational messaging – all supporting high compliance levels

Using ERT’s Trial Oversight tools, you can effectively manage and monitor patient performance and risk to keep your oncology clinical trial on track.

Discover how to better motivate and engage oncology patients during a trial and their views on embracing digital data capture technology. Download our latest survey results

The rise of precision medicine and targeted therapies has led to additional endpoints and eligibility criteria, as well as novel trial designs, such as basket and umbrella trials. These complexities not only impact sites and study teams but also contribute to decreased patient compliance and extended development timelines.

SOLUTION: ERT’s team of more than 100 scientific and regulatory experts will consult on your protocol design to ensure your methods for data collection reflect best practices. They’ll also provide study and device recommendations.

Then, getting your trial up and running couldn’t be faster or simpler with the pre-built libraries provided by our eCOA on-demand solution.

During the study, patients can complete their assessments on a device which suits them, including their own mobile device (through Bring Your Own Device, or BYOD), enhancing their experience, driving higher compliance levels, and overcoming some of the burdens that patients face when participating in today’s increasingly complex clinical trials.

Intuitive data visualizations produced by our Trial Oversight solution simplifies the analysis of high-volume, high-velocity, and high-complexity data.

Together, our technology and expertise can significantly simplify the clinical trial process for patients, sites and sponsors